Name | Hypoxanthine-¹³C2,¹⁵N |
---|---|
Synonyms |
6-Hydroxypurine-13C2,15N
(4,5-13C2,7-15N)-3,9-Dihydro-6H-purin-6-one 1,9-Dihydro-6H-purin-6-one-13C2,15N 3H-Purin-6-ol-13C2,15N 6-Hydroxy-1H-purine-13C2,15N 6H-Purin-6-one-4,5-13C2-7-15N, 3,9-dihydro- |
Description | Hypoxanthine-13C2,15N is a 15N-labeled and 13C-labled DL-Cystine[1]. |
---|---|
Related Catalog | |
In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[75]. |
References |
Density | 1.9±0.1 g/cm3 |
---|---|
Melting Point | >300° C (dec.) |
Molecular Formula | C313C2H4N315NO |
Molecular Weight | 139.09 |
Exact Mass | 139.042252 |
Index of Refraction | 1.903 |